Qualigen Therapeutics Inc (QLGN) stock is down -11.11% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 4 out of a possible 100.
That rank is primarily influenced by a fundamental score of 0. QLGN stock has a mean target price of 10. This means analysts expect the stock to increase 177.78% over the next 12 months. QLGN's rank also includes a short-term technical score of 6. The long-term technical score for QLGN is 7.
What's Happening with QLGN Stock Today
Qualigen Therapeutics Inc (QLGN) stock has gained 1.69% while the S&P 500 has risen 0.78% as of 9:51 AM on Tuesday, Dec 15. QLGN has risen $0.06 from the previous closing price of $3.54 on volume of 221,400 shares. Over the past year the S&P 500 is higher by 15.18% while QLGN is down -11.11%. QLGN lost -$4.68 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
